Atherogenic changes of low-density lipoprotein susceptibility to oxidation, and antioxidant enzymes in pulmonary tuberculosis

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 268-273

  Nezami, Nariman ^a   Ghorbanihaghjo, Amir ^b   Rashtchizadeh, Nadereh ^c   Argani, Hassan ^d   Tafrishinejad, Arash ^a   Ghorashi, Sona ^e   Hajhosseini, Babak ^f  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISLAMIC AZAD UNIVERSITY   (Iran)

^f STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Glutathione peroxidase; Low density lipoprotein cholesterol; Malondialdehyde; Oxidation; Oxidative stress; Pulmonary; Superoxide dismutase; Tuberculosis

Indexed keywords

GLUTATHIONE PEROXIDASE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ADULT; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME METABOLISM; ERYTHROCYTE; HUMAN; LIPOPROTEIN BLOOD LEVEL; LUNG TUBERCULOSIS; MALE; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; ERYTHROCYTES; GLUTATHIONE PEROXIDASE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OXIDATIVE STRESS; OXYGEN; SUPEROXIDE DISMUTASE; TUBERCULOSIS, PULMONARY;

EID: 79960236080     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.025     Document Type: Article

References (30)

1. Iademarco M.F., Castro K.G. Epidemiology of tuberculosis. Semin Respir Infect 2003, 18:225-240.
2. Kiechl S., Egger G., Mayr M., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103:1064-1070.
3. George J., Shoenfeld Y., Gilburd B., Afek A., Shaish A., Harats D. Requisite role for interleukin-4 in the acceleration of fatty streaks induced by heat shock protein 65 or Mycobacterium tuberculosis. Circ Res 2000, 86:1203-1210.
4. Selek S., Cosar N., Kocyigit A., et al. PON1 activity and total oxidant status in patients with active pulmonary tuberculosis. Clin Biochem 2008, 41:140-144.
5. Halliwell B., Aruoma O.I. DNA damage by oxygen-derived species Its mechanism and measurement in mammalian systems. FEBS Lett 1991, 281:9-19.
6. Lankin V. Free radical lipoperoxidation during atherosclerosis. Free Radic Biol Med 1994, 16:8.
7. Halliwell B., Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990, 186:1-85.
8. Huh H.Y., Pearce S.F., Yesner L.M., Schindler J.L., Silverstein R.L. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996, 87:2020-2028.
9. Selwyn A.P., Kinlay S., Libby P., Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation 1997, 95:5-7.
10. Takei A., Huang Y., Lopes-Virella M.F. Expression of adhesion molecules by human endothelial cells exposed to oxidized low density lipoprotein. Influences of degree of oxidation and location of oxidized LDL. Atherosclerosis 2001, 154:79-86.
11. Wiid I., Seaman T., Hoal E.G., Benade A.J., Van Helden P.D. Total antioxidant levels are low during active TB and rise with anti-tuberculosis therapy. IUBMB Life 2004, 56:101-106.
12. Lamsal M., Gautam N., Bhatta N., Toora B.D., Bhattacharya S.K., Baral N. Evaluation of lipid peroxidation product, nitrite and antioxidant levels in newly diagnosed and two months follow-up patients with pulmonary tuberculosis. Southeast Asian J Trop Med Public Health 2007, 38:695-703.
13. Ghorbanihaghjo A., Rashtchizadeh N., Rohbaninoubar M., Vatankhah A., Rafi A. Oxidative stress in patients with pulmonary tuberculosis. Saudi Med J 2006, 27:1075-1077.
14. Yagi K. Assay for blood plasma or serum. Methods Enzymol 1984, 105:328-331.
15. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
16. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-500.
17. Nathan C., Shiloh M.U. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000, 97:8841-8848.
18. Jack C.I., Jackson M.J., Hind C.R. Circulating markers of free radical activity in patients with pulmonary tuberculosis. Tuberc Lung Dis 1994, 75:132-137.
19. Evans P., Halliwell B. Micronutrients: oxidant/antioxidant status. Br J Nutr 2001, 85(Suppl. 2):S67-74.
20. Filteau S.M., Tomkins A.M. Micronutrients and tropical infections. Trans R Soc Trop Med Hyg 1994, 88(1-3):26.
21. Karyadi E., Schultink W., Nelwan R.H., et al. Poor micronutrient status of active pulmonary tuberculosis patients in Indonesia. J Nutr 2000, 130:2953-2958.
22. Jetan C.A., Jamaiah I., Rohela M., Nissapatorn V. Tuberculosis: an eight-year (2000-2007) retrospective study at the University of Malaya Medical Centre (UMMC), Kuala Lumpur, Malaysia. Southeast Asian J Trop Med Public Health 2010, 41:378-385.
23. Koyanagi A., Kuffo D., Gresely L., Shenkin A., Cuevas L.E. Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis. Ann Trop Med Parasitol 2004, 98:391-399.
24. Fridovich I Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995, 64:97-112.
25. Safarian M.D., Karapetian E.T. Dynamics of the activity of antioxidant enzymes in the blood of patients with pulmonary tuberculosis. Probl Tuberk 1990, 60-61.
26. Spagnolo L., Toro I., D'Orazio M., et al. Unique features of the sodC-encoded superoxide dismutase from Mycobacterium tuberculosis, a fully functional copper-containing enzyme lacking zinc in the active site. J Biol Chem 2004, 279:33447-33455.
27. Seres T., Knickelbein R.G., Warshaw J.B., Johnston R.B. The phagocytosis-associated respiratory burst in human monocytes is associated with increased uptake of glutathione. J Immunol 2000, 165:3333-3340.
28. Esterbauer H., Wag G., Puhl H. Lipid peroxidation and its role in atherosclerosis. Br Med Bull 1993, 49:566-576.
29. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989, 6:67-75.
30. Chisolm G.M., Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic Biol Med 2000, 28:1815-1826.